Alpine Immune Sciences
Seattle, WA
Alpine Immune Sciences, Inc. (AIS) focuses on developing novel protein-based cancer immunotherapies using its proprietary variant ig domain (vIgD) platform technology. The Company develops TIP technology, based on the vIgD platform, to enhance engineered cellular therapies. AIS offers a platform to interact with multiple targets, including many present in the immune synapse.
alpineimmunesciences.comCompany Details
Founded
- 2015
Employees
- Between 100 - 500 employees
Raised
- $515,300,000
Headquarters Location
- Seattle, WA
Public
- Yes
Acquired
- Yes
CEO
Mitchell Gold
Founders
- Michael KornackerMitchell GoldRyan Swanson
Company Collections
These are collections Alpine Immune Sciences is a part of. Click on the collection name to view similar companies.